Biotech News

• Jacksonville,  Services,  Medical,  Health,  Technology

  Parkway Prosthodontics Achieves Breakthrough Full-Arch Reconstruction Case
• Business,  Medical

  Postmortem Pathology Expands to Phoenix: Bringing Families Answers During Their Most Difficult Moments
• Consumer,  Retail

  EPP Pricing Platform announces leadership transition to support long-term growth and continuity
• Technology,  Legal,  Financial

  Stipenda Appoints David Epstein as Chief Operating Officer
• Health,  Non-profit

  Metavalis Launches Massive Community Coat Drive in Branson to Support Local Residents
• Business,  Medical,  Health,  Non-profit

  Crossroads4Hope Welcomes New Trustees to Board of Directors as Organization Enters 25th Year of Caring
• Miami,  Medical,  Health,  Marketing,  Banking,  Stocks,  Financial

  High-Impact Mental Health Platform Approaching a Defining Regulatory Moment: Eclipsing 70,000 Patients on Real World Use of Ketamine: N ASDAQ: NRXP
• LactaLogics Nears Completion of Donor Milk Facility for NICU Babies
• Miami,  Medical,  Health,  Marketing,  Banking,  Stocks,  Financial

  High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030
• Miami,  Medical,  Health,  Marketing,  Banking,  Stocks,  Financial

  FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
• Miami,  Medical,  Health,  Marketing,  Banking,  Stocks,  Financial

  Revenue Expansion, Regulatory Momentum, and a Leadership Position in the $750 Million Suicidal Depression: NRx Pharmaceuticals (N A S D A Q: NRXP)